Search results
Showing 7651 to 7665 of 8218 results
This agreement constitutes the entire agreement between the Organisation and NICE relating to the Confidential Information
The NICE board sets out our strategic priorities and policies.
Holding our meetings in public supports our commitment to having processes in place that are rigorous, open, and transparent.
NICE helps practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
Access a range of resources including healthcare databases, e-journal and ebooks.
The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.
Past technology appraisal appeals and decisions
Research to access pathway for investigational drugs for COVID-19 (RAPID C-19)
RAPID C-19’s role in reviewing potential COVID-19 treatments has now ended because we have moved back to routine commissioning arrangements for these treatments.
NICE's business plan, annual report, charter, transformation story, gender pay gap report, framework agreement and other publications.
Home Implementing NICE guidance...
Home What NICE does {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
People living with metastatic prostate cancer in England will gain access to a new treatment combination from today (Friday, 24 October), following a recommendation by NICE.
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Find out more about NICE technology appraisals advisory committee D members